- Accesswire•4 days agoBiotech's Rise Shows No Sign of Slowing Dow in 2017: Today's Reports on Pernix Therapeutics and Brainstorm Cell Therapeutics
NEW YORK, NY / ACCESSWIRE / February 23, 2017 / The Biotech Industry has posted some impressive gains since election result and the rally has continued for the larger part of this year. Both the iShares ...
- GlobeNewswire•4 days ago
MORRISTOWN, N.J., Feb. 23, 2017-- Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company with a focus on Pain and CNS conditions, announced today that it received a favorable opinion in ...
- GlobeNewswire•24 days ago
MORRISTOWN, N.J., Feb. 03, 2017-- Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company with a focus on Pain and CNS conditions, today provided an update on the Company’ s arbitration ...
PTX : Summary for Pernix Therapeutics Holdings, I - Yahoo Finance
Pernix Therapeutics Holdings, Inc. (PTX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||2.86 x 3000|
|Ask||3.45 x 100|
|Day's Range||2.95 - 3.30|
|52 Week Range||0.39 - 4.80|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.14|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|